Comparative Study between Quantitative Digital Image Analysis and Fluorescence In Situ Hybridization of Breast Cancer Equivocal HER2 2+Cases

被引：0
|
作者：
Ayad, E. [1 ]
Mansy, M. [1 ]
Elwi, D. [1 ]
Salem, M. [1 ]
Salama, M. [2 ,3 ]
Kayser, K. [4 ]
机构：
[1] Cairo Univ, Dept Pathol, Fac Med, Cairo, Egypt
[2] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[3] ARUP Reference Lab, Salt Lake City, UT USA
[4] Humboldt Univ, Dept Pathol, D-10099 Berlin, Germany
来源：
ANALYTICAL CELLULAR PATHOLOGY | 2014年 / 2014卷
关键词：
D O I：
10.1155/2014/608254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Digital Image Analysis of HER2 Fluorescence In-Situ Hybridization: A Useful Tool to Resolve Equivocal HER2 Cases
    Wilcock, Diane
    Moore, Kristina
    Gulbahce, H. Evin
    Sirohi, Deepika
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 205 - 206
  • [2] Digital Image Analysis of HER2 Fluorescence In-Situ Hybridization: A Useful Tool to Resolve Equivocal HER2 Cases
    Wilcock, Diane
    Moore, Kristina
    Gulbahce, H. Evin
    Sirohi, Deepika
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 205 - 206
  • [3] Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer A Cohort Study Emphasizing Equivocal Cases
    Shao, Tiffany
    Wood, Martha
    Wing, Anthony
    Hnatovska, Marta
    Mendes, Maria
    Mullen, J. Brendan
    Chang, Martin C.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (03) : 339 - 345
  • [4] HER2 testing in metastatic breast cancer - is reflex in situ hybridization necessary in cases that are equivocal by immunohistochemistry?
    Liwski, C. R.
    Castonguay, M.
    Barnes, P.
    Bethune, G.
    Rayson, D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 : S27 - S28
  • [5] Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer
    Wilcock, Diane M.
    Moore, Kristina H.
    Rowe, Leslie
    Mahlow, Jonathan
    Jedrzkiewicz, Jolanta
    Cleary, Allison S.
    Lomo, Lesley
    Ruano, Ana L.
    Gering, Maarika
    Bradshaw, Derek
    Maughan, Meghan
    Tran, Phuong
    Burlingame, Jesse
    Davis, Richard
    Affolter, Kajsa
    Albertson, Daniel J.
    Adelhardt, Parisa
    Kim, Jong Take
    Coleman, Joshua F.
    Deftereos, Georgios
    Gulbahce, Evin H.
    Sirohi, Deepika
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (12) : 1402 - 1412
  • [6] Bright-Field HER2 Dual In Situ Hybridization (DISH) Assay vs Fluorescence In Situ Hybridization (FISH) Focused Study of Immunohistochemical 2+Cases
    Gao, Faye F.
    Dabbs, David J.
    Cooper, Kristine L.
    Bhargava, Rohit
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (01) : 102 - 110
  • [7] What to expect from the 2018 ASCO/CAP HER2 guideline in the reflex in situ hybridization test of immunohistochemically equivocal 2+cases?
    Curado, Monica
    Caramelo, Ana Sofia
    Eloy, Catarina
    Polonia, Antonio
    VIRCHOWS ARCHIV, 2019, 475 (03) : 303 - 311
  • [8] Resolving Equivocal HER2 Status in Breast Cancer by Automated and Quantitative RNA Chromogenic In Situ Hybridization (CISH)
    Wang, Z.
    Bui, S.
    Wang, H.
    Su, N.
    Ma, X-J
    Luo, Y.
    Tubbs, R. R.
    MODERN PATHOLOGY, 2012, 25 : 72A - 72A
  • [9] Resolving Equivocal HER2 Status in Breast Cancer by Automated and Quantitative RNA Chromogenic In Situ Hybridization (CISH)
    Wang, Z.
    Bui, S.
    Wang, H.
    Su, N.
    Ma, X-J
    Luo, Y.
    Tubbs, R. R.
    LABORATORY INVESTIGATION, 2012, 92 : 72A - 72A
  • [10] A Validation Study of HER2 Immunohistochemistry Digital Imaging Analysis and its Correlation with HER2 Fluorescence In Situ Hybridization Results in Breast Carcinoma
    Hartage, Ramon
    Li, Aidan
    Hammond, Scott
    Parwani, Anil
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1458 - 1459
12345